What medication is used for MOG antibody disease? An in-depth look
•
4 min read
Approximately 50% of adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) will experience a relapsing course. The treatment approach for MOGAD is highly individualized, addressing both acute inflammatory attacks and long-term relapse prevention. So, what medication is used for MOG antibody disease to manage this complex autoimmune condition? This article explores the range of pharmacological and non-pharmacological interventions used today.
